Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
myDNA is a genomics technology company that specializes in pharmacogenomics (PGx) and personalized wellness. The company provides genetic testing kits and a digital platform that interprets DNA data to offer actionable insights regarding medication efficacy, nutrition, and physical fitness. Their clinical focus includes optimizing drug prescriptions for mental health, pain, and heart conditions by analyzing how an individual's genetic makeup affects drug metabolism. In 2021, myDNA significantly expanded its laboratory and direct-to-consumer capabilities through a merger with Gene by Gene, the parent company of FamilyTreeDNA. The company's mission is to empower consumers and healthcare professionals with genetic information to improve health outcomes and personalize daily wellness routines. By combining clinical-grade genetic analysis with user-friendly digital reports, myDNA bridges the gap between complex genomic data and everyday health decisions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on myDNA Media.